Director Augustine Chow retires from Imunon Board after 16 years

Imunon, Inc.

Augustine Chow, Ph.D., retired as Class I director effective June 14, 2023.
He served on the Board since 2007 and was on Compensation and Audit Committees.
Company did not nominate him for re-election due to age 70 and 16-year tenure.
Retirement was not due to any disagreement with management or Board.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Augustine Chow

Class I Director

IMNN · Imunon, Inc.

Effective: 2023-06-14
Filed: June 14, 2023, 7:59 PM ET

On June 14, 2023, Augustine Chow, Ph.D., a Class I member of the Board of Directors (the “Board”) of Imunon, Inc. (the “Registrant”), retired from the Registrant’s Board upon conclusion of the 2023 Annual Meeting of Stockholders (the “Meeting”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Augustine Chow retired as Class I Director at Imunon, Inc..

Action: retired
Role: Class I Director

Exact text from the filing

On June 14, 2023, Augustine Chow, Ph.D., a Class I member of the Board of Directors (the “Board”) of Imunon, Inc. (the “Registrant”), retired from the Registrant’s Board upon conclusion of the 2023 Annual Meeting of Stockholders (the “Meeting”).

View on SEC.gov

Imunon, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-021229

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.